UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000043241
Receipt number R000049351
Scientific Title Effect of cognitive impairment and assisted PD on adverse event in older patients undergoing peritoneal dialysis.
Date of disclosure of the study information 2022/12/31
Last modified on 2023/05/13 11:10:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of cognitive impairment and assisted PD on adverse event in older patients undergoing peritoneal dialysis.

Acronym

Effect of cognitive impairment and assisted PD on adverse event in older patients undergoing peritoneal dialysis.

Scientific Title

Effect of cognitive impairment and assisted PD on adverse event in older patients undergoing peritoneal dialysis.

Scientific Title:Acronym

Effect of cognitive impairment and assisted PD on adverse event in older patients undergoing peritoneal dialysis.

Region

Japan


Condition

Condition

End stage renal disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to determine the risk of adverse event in older patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

over all mortality

Key secondary outcomes

technical failure, peritonitis, exit-cite infection, hospitalization


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) over 65 years old; (2) had been on PD for at least three months; (3) clinically stable

Key exclusion criteria

(1) peritonitis or other severe infection needing intravenous antibiotic use, trauma, operation during 30 days preceding enrolment; (2) history of stroke or amputation; (3) expected to cease PD within 6-month; (4) hospitalized within the previous three months; (5) cognitive impairment that difficult to understand evaluation.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Yabe

Organization

Seirei Christopher University

Division name

Department of Physical therapy

Zip code

433-8558

Address

3453 Mikatahara, kita-ku, Hamamatsu, Shizuoka

TEL

0534391400

Email

yabe0909@gmail.com


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Yabe

Organization

Seirei Christopher University

Division name

Department of Physical therapy

Zip code

433-8558

Address

3453 Mikatahara, kita-ku, Hamamatsu, Shizuoka

TEL

0534391400

Homepage URL


Email

yabe0909@gmail.com


Sponsor or person

Institute

Seirei christopher university

Institute

Department

Personal name



Funding Source

Organization

Japan society for the promotion of science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Nagoya Kyoritsu Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Seirei Christopher University

Address

3453 Mikatahara3453, Kita-ku Hamamatsu

Tel

09035886425

Email

yabe0909@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋共立病院


Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 31 Day


Related information

URL releasing protocol

https://link.springer.com/article/10.1007/s10157-022-02199-9

Publication of results

Published


Result

URL related to results and publications

https://link.springer.com/article/10.1007/s10157-022-02199-9

Number of participants that the trial has enrolled

40

Results

Six and 16 patients experienced peritonitis and exit-site infection during follow-up, respectively. Kaplan-Meier analysis and log-rank tests revealed that the without CI and without assistance group was significantly associated with exit-site infection.

Results date posted

2022 Year 05 Month 06 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The median MoCA-J score was 21 points, and 25 patients performed the exit-site care procedure with assistance from their family members. As a result of grouping, 8, 8, and 17 patients were assigned to the without CI and without assistance, without CI and with assistance, and with CI and with assistance groups, respectively.

Participant flow

Among the 40 patients screened, six did not consent to participate in the study and one patient could not understand the evaluation due to dementia. Hence, 33 patients were finally included in the analysis.

Adverse events

The incidence rates of peritonitis were 0.01 in the overall population, 0 in the without CI and without assistance group, 0.02 in the without CI and with assistance group, and 0.01 in the with CI and with assistance group. The incidence rate of exit-site infections was 0.46 in the overall population, 1.63 in the without CI and without assistance group, 0.49 in the without CI and with assistance group, and 0.21 in the with CI and with assistance group. Tunnel infections associated with exit-site infections were suspected in two patients.

Outcome measures

Japanese version of the Montreal Cognitive Assessment (MoCA-J)
exit-site infection
Peritonitis

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2016 Year 04 Month 01 Day

Date of IRB

2017 Year 02 Month 07 Day

Anticipated trial start date

2017 Year 04 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

cohort study
enrolled between 1 April 2017 and 31 December 2018


Management information

Registered date

2021 Year 02 Month 04 Day

Last modified on

2023 Year 05 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000049351


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name